Text-only version of this email
LIXTE Biotechnology Holdings, Inc.
LIXTE Biotechnology Holdings, Inc. has just released the following news:
LIXTE BIOTECHNOLOGY HOLDINGS ANNOUNCES COLLABORATION ON A NEW COLON CANCER CLINICAL TRIAL
Click here to read the full article
If you have any questions, or would like to contact Investor Relations, please reply to this email.
LIXTE Biotechnology Holdings, Inc.
680 E Colorado Blvd., Suite 180, Pasadena, CA 91101 United States of America
To change your subscription preferences, please click here.
Show all